Maplight Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.17

-1.11 (-8.36%)

As of Aug 9, 10:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +419.2% upside

Low Target $44.21

Average Target $63.19

High Target $83.67

Current Price $12.17

Current
$12.17

Target
$63.19

$44.21 $63.19 avg $83.67

Scenario Analysis

Bear Case

$44.21

263.3%

Low target

Base Case

$63.19

+419.2%

Avg target

Bull Case

$83.67

+587.5%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$40.43

-69.9% from high

52-Week Low

$9.10

+33.7% from low

Target vs 52W High

$63.19

+56.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%